Designing of an ELISA Method for the Measurement of Serum Antibodies against Interferon-beta and the Study of the Frequency of these Antibodies in Patients with Multiple Sclerosis Treated with CinnoVex

Background: Multiple sclerosis (MS) is a demyelinating disease of the central nervous system. Interferon-beta (IFN-β) was the first disease modifying drug to be approved for the treatment of MS. Some MS patients treated with IFN-β develop antibodies to the drug. Anti-IFN-β antibodies can reduce both...

Full description

Bibliographic Details
Main Authors: Nasrin Zare, Sayyed Hamid Zarkesh Esfahani, Vahid Shaygannejad, Marjan Gharagozloo
Format: Article
Language:fas
Published: Vesnu Publications 2012-11-01
Series:مجله دانشکده پزشکی اصفهان
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/2002